Matching trials
1,962 results
- A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment: Complete Statistical AnalysisIndependent statistical analysis of A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment: primary endpoint results, effect estimate…
- A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044): Complete Statistical AnalysisIndependent statistical analysis of A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19: Complete Statistical AnalysisIndependent statistical analysis of A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission: Complete Statistical AnalysisIndependent statistical analysis of A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission:…
- A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension: Complete Statistical AnalysisIndependent statistical analysis of A Study of Aspirin and Simvastatin in Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00384865).
- A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1): Complete Statistical AnalysisIndependent statistical analysis of A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Auxora in Patients With Critical COVID-19 Pneumonia: Complete Statistical AnalysisIndependent statistical analysis of A Study of Auxora in Patients With Critical COVID-19 Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04661540).
- A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.: Complete Statistical AnalysisIndependent statistical analysis of A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF): Complete Statistical AnalysisIndependent statistical analysis of A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF): primary endpoint results, effect estimate with confidence interval,…
- A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS: Complete Statistical AnalysisIndependent statistical analysis of A Study of Baricitinib (LY3009104) in Adult and Pediatric Japanese Participants With NNS/CANDLE, SAVI, and AGS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of BAX 888 in Male Adults With Severe Hemophilia A: Complete Statistical AnalysisIndependent statistical analysis of A Study of BAX 888 in Male Adults With Severe Hemophilia A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation: Complete Statistical AnalysisIndependent statistical analysis of A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma: Complete Statistical AnalysisIndependent statistical analysis of A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Study of Belimumab in the Prevention of Kidney Transplant Rejection: Complete Statistical AnalysisIndependent statistical analysis of A Study of Belimumab in the Prevention of Kidney Transplant Rejection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001): Complete Statistical AnalysisIndependent statistical analysis of A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor: Complete Statistical AnalysisIndependent statistical analysis of A Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074): Complete Statistical AnalysisIndependent statistical analysis of A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Study of CCX140-B in Subjects With Primary FSGS and Nephrotic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL): Complete Statistical AnalysisIndependent statistical analysis of A Study of CS1001 in Subjects With Relapsed or Refractory Extranodal Natural Killer/ T Cell Lymphoma(ENKTL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST): Complete Statistical AnalysisIndependent statistical analysis of A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Complete Statistical AnalysisIndependent statistical analysis of A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval,…
- A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum: Complete Statistical AnalysisIndependent statistical analysis of A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05569252).
- A Study of DS-7011a in Patients With Systemic Lupus Erythematosus: Complete Statistical AnalysisIndependent statistical analysis of A Study of DS-7011a in Patients With Systemic Lupus Erythematosus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05638802).
- A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations: Complete Statistical AnalysisIndependent statistical analysis of A Study of E6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study of E7080 in Subjects With Advanced Thyroid Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of E7080 in Subjects With Advanced Thyroid Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01728623).
- A Study of E7820 in People With Bone Marrow (Myeloid) Cancers: Complete Statistical AnalysisIndependent statistical analysis of A Study of E7820 in People With Bone Marrow (Myeloid) Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer: primary…
- A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203): Complete Statistical AnalysisIndependent statistical analysis of A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis: primary endpoint results, effect estimate with confidence interval,…
- A Study of Fisetin to Treat Carpal Tunnel Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Study of Fisetin to Treat Carpal Tunnel Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05416515).
- A Study of FMT in Patients With AML Allo HSCT in Recipients: Complete Statistical AnalysisIndependent statistical analysis of A Study of FMT in Patients With AML Allo HSCT in Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Study of Galunisertib in Participants With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of A Study of Galunisertib in Participants With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02008318).
- A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive…
- A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM): Complete Statistical AnalysisIndependent statistical analysis of A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…